Sanofi Consumer Healthcare India Ltd. (SANOFICONR) fundamentals
Sanofi Consumer Healthcare India Ltd. is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as SANOFICONR (ISIN INE0UOS01011). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Sanofi Consumer Healthcare India Ltd. does
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
Valuation and market data
| Last close | ₹4180.00 |
|---|---|
| Market capitalisation | ₹9,625 crore |
| Enterprise value | ₹9,285 crore |
| P/E (TTM) | 40.09 |
| Price to book | 25.07 |
| Price to sales (TTM) | 6.05 |
| Book value per share | ₹166.76 |
| Dividend yield | 179.43% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Fri Sep 13 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Dec 2025 | ₹897 crore | ₹320 crore | ₹240 crore | 104.27 |
| Mar 2025 | ₹897 crore | ₹320 crore | ₹240 crore | 0.00 |
| Dec 2024 | ₹738 crore | ₹247 crore | ₹181 crore | 78.59 |
| Mar 2024 | ₹738 crore | ₹247 crore | ₹181 crore | 0.00 |
| Dec 2023 | ₹560 crore | ₹219 crore | ₹165 crore | 71.60 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 71.3% |
|---|---|
| Foreign institutions (FII) | 2.6% |
| Mutual funds | 13.0% |
| Other domestic institutions | 4.8% |
| Retail and others | 8.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.